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Abstract
Background: Host defence peptides (HDPs), also known as antimicrobial peptides (AMPs), have emerged as
potential new therapeutics and their antimicrobial spectrum covers a wide range of target organisms. However,
the mode of action and the genetics behind the bacterial response to HDPs is incompletely understood and such
knowledge is required to evaluate their potential as antimicrobial therapeutics. Plectasin is a recently discovered
HDP active against Gram-positive bacteria with the human pathogen, Staphylococcus aureus (S. aureus) being
highly susceptible and the food borne pathogen, Listeria monocytogenes (L. monocytogenes) being less sensitive. In
the present study we aimed to use transposon mutagenesis to determine the genetic basis for S. aureus and
L. monocytogenes susceptibility to plectasin.
Results: In order to identify genes that provide susceptibility to plectasin we constructed bacterial transposon
mutant libraries of S. aureus NCTC8325-4 and L. monocytogenes 4446 and screened for increased resistance to the
peptide. No resistant mutants arose when L. monocytogenes was screened on plates containing 5 and 10 fold
Minimal Inhibitory Concentration (MIC) of plectasin. However, in S. aureus, four mutants with insertion in the heme
response regulator (hssR) were 2-4 fold more resistant to plectasin as compared to the wild type. The hssR
mutation also enhanced resistance to the plectasin-like defensin eurocin, but not to other classes of HDPs or to
other stressors tested. Addition of plectasin did not influence the expression of hssR or hrtA, a gene regulated by
HssR. The genome of L. monocytogenes LO28 encodes a putative HssR homologue, RR23 (in L. monocytogenes
EGD-e lmo2583) with 48% identity to the S. aureus HssR, but a mutation in the rr23 gene did not change the
susceptibility of L. monocytogenes to plectasin.
Conclusions: S. aureus HssR, but not the homologue RR23 from L. monocytogenes, provides susceptibility to the
defensins plectasin and eurocin. Our data suggest that a functional difference between response regulators HssR
and RR23 is responsible for the difference in plectasin susceptibility observed between S. aureus and
L. monocytogenes.
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Background
Humans are living in a constant struggle with infectious
microorganisms and whilst improved hygiene has been
essential to control such organisms, one of the major
steps forward has been the discovery and use of antibio-
tics. However, the high rate at which bacteria become
resistant to currently used antibiotics is regarded as a
major threat to the future treatment of infectious dis-
eases in both humans and livestock [1,2]. Therefore,
there is a growing demand for new types of antimicro-
bial compounds and interest is focused on host defence
peptides (HDPs) as novel therapeutic agents. HDPs are
a unique and diverse group of peptides, which can be
grouped into different classes, based on their amino acid
composition and structure. In humans and other mam-
mals, the defensins and the cathelicidins constitute the
two main HDP families. The cathelicidins vary widely in
sequence, composition and structure, but share a highly
conserved N-terminal structural domain (cathelin)
linked to a highly variable cathelicidin peptide domain
[3]. The defensins are more uniform, small cysteine-rich
cationic peptides [4]. Defensins have well-established
antimicrobial activity against a broad spectrum of patho-
gens, and in addition they have been shown to have
immunostimulatory functions on both innate and adap-
tive immunity [5]. This has prompted a massive interest
in synthetic defensins as novel antimicrobial candidates
for therapeutic use.
Recently, the antimicrobial peptide, plectasin isolated
from a saprophytic fungus, was described [6]. Plectasin
is a defensin, which has broad activity against several
species of Gram-positive bacteria and combined with
very low toxicity in mice and on human keratinocytes
and erythrocytes, plectasin holds promise as a novel
anti-infective treatment [6,7].
In the present study, we addressed the response of
two human pathogens, S. aureus and L. monocytogenes
to plectasin. These two pathogens differ in sensitivity
towards plectasin with MIC values of 16-32 mg/L for
methicillin resistant S. aureus (MRSA), and above 64
mg/L for the less sensitive L. monocytogenes [6,7]. In
addition, the two bacteria represent different routes of
infection and may be exposed to different arrays of
HDPs. S. aureus is a hospital- and community-acquired
pathogen that causes a wide range of diseases including
septicaemia, toxic-shock syndrome and food poisoning
[8]. S. aureus is primarily extracellular and produces
extracellular enzymes and toxins that cause damage to
tissues. L. monocytogenes is a food borne pathogen caus-
ing gastroenteritis or septicaemia and meningitis in
immunocompromised individuals [9]. As opposed to the
infection mode of S. aureus, L. monocytogenes is an
intracellular pathogen, able to spread from cell to cell
within the host and thereby guarded against circulating
immune factors.
The purpose of the present study was to investigate if
resistance towards plectasin could be induced in S. aur-
eus and L. monocytogenes by transposon mutagenesis
and if this resistance would affect the mutants’ response
to other groups of antimicrobial peptides.
Results
Plectasin does not cause cellular leakage
Many antimicrobial peptides affect the structural or
functional integrity of the bacterial membrane, leading
to pore formation and subsequently leakage of intracel-
lular components [10]. Therefore, we examined the
extracellular protein-profile by SDS-PAGE analysis.
When the two Gram-positive pathogens, S. aureus and
L. monocytogenes, were grown with and without plecta-
sin, there was no difference, indicating that the bacteria
are not leaking macromolecules (data not shown). To
support this notion, we determined the effect of plecta-
sin on the membrane of the two species by measuring
the amount of ATP leakage. In this study we also
included three peptides representing each of the antimi-
crobial peptide groups: the plectasin-like defensin euro-
cin, the linear arginine-rich peptide protamine and the
a-helical peptide novicidin [11]. ATP leakage profiles
were similar for L. monocytogenes and S. aureus but dif-
fered between peptides. When either of the pathogens
was exposed to the defensins, plectasin or eurocin, we
found that the intracellular ATP concentration remained
at the same level as the controls treated with peptide
dilution buffer only (Figure 1). This indicates that the
defensins do not cause pore formation or membrane
disruption in any of the bacteria. In contrast, protamine
and novicidin resulted in increased ATP leakage thus
suggesting that they are disrupting the membrane
(Figure 1). Our finding is in agreement with recent
results which revealed that plectasin targets the bacterial
cell wall precursor Lipid II and does not compromise
the membrane integrity [12].
Even though plectasin is known to interact with Lipid
II, an increasing amount of evidence has established that
HDPs can have multiple targets, including cytoplasmic
and intracellular targets [13]. One such target is the bac-
terial DNA. However, we were unable to demonstrate
binding of plectasin or eurocin to DNA when examined
by in vitro gel retardation (data not shown).
Identification of genes providing increased resistance
to plectasin
In order to identify genes involved in the bacterial suscept-
ibility towards plectasin, we created transposon mutant
libraries in S. aureus 8325-4 and L. monocytogenes 4446
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using bursa aurealis and Tn917, respectively. MIC values
on agar plates were determined for the two wild types and
the two transposon libraries were subsequently screened
on plectasin-concentrations corresponding to 4, 5 or 10
fold MIC. After screening 40,000 colonies of L. monocyto-
genes transposon mutants, we found no mutants with
increased resistance.
Screening of the S. aureus mutant library resulted in
identification of four colonies with increased resistance,
in which the transposon element had inserted into the
heme response regulator hssR that together with hssS
forms an operon, encoding a two component system
(TCS) [14]. S. aureus require iron, and during infection,
it can obtain iron through the haemolysin-mediated
rupture of erythrocytes [15]. While heme is an impor-
tant source of iron, high concentrations are toxic to
S. aureus due to the reactivity of the molecule [16].
Therefore, the HssRS TCS is able to sense high concen-
trations of heme and induces the expression of hrtAB,
encoding the HrtAB efflux pump that protects the cells
against heme-mediated cell damage [16,17].
To control whether the selected plectasin concentra-
tions induce spontaneous mutations, S. aureus and
L. monocytogenes wild types were grown on TSB and
BHI, respectively, with 4, 5 or 10 fold MIC. We found
that no spontaneous mutations, leading to changes in
sensitivity, occurred.
No mutants were obtained from the screening of the
transposon mutant library of L. monocytogenes for
altered resistance to plectasin. However, a homologous
system in L. monocytogenes LO28 was identified by
homology search and we found that the response regu-
lator RR23 has a higher identity (48%) to HssR com-
pared to other response regulators (30-35%) from
L. monocytogenes LO28. In addition, RR23 show 99%
amino acid sequence identity to L. monocytogenes
EGD-e lmo2583, previously identified as an HssR homo-
logue [14]. To evaluate the importance of HssR on
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Figure 1 Measurement of ATP leakage from Staphylococcus aureus after treatment with plectasin (A), eurocin (B), protamine (C), and
novicidin (D). Measurement of intracellular (IC) and extracellular (EC) ATP after treatment with plectasin (500 μg/ml), eurocin (500 μg/ml),
protamine (1,000 μg/ml), novicidin (1,000 μg/ml), or peptide dilution buffer. Treatment with the two defensins does not lead to leakage of
intracellular ATP, whereas treatment with protamine and novicidin lead to leakage of ATP. Representative results from S. aureus are shown as
treatment of S. aureus and L. monocytogenes resulted in similar leakage profiles. The experiment shown is representative of two independent
experiments.
Thomsen et al. BMC Microbiology 2010, 10:307
http://www.biomedcentral.com/1471-2180/10/307
Page 3 of 10
sensitivity to plectasin of a bacterium other than S. aur-
eus, a L. monocytogenes rr23 mutant was included in the
experiments.
HssR modulates resistance to defensins
In order to validate the phenotypes obtained by our
S. aureus transposon mutant 8325-4 hssR::bursa, we
transduced the transposon element from 8325-4 hssR::
bursa to S. aureus 8325-4 wild type, giving the mutant
8325-4 hssR. In addition, we included another S. aureus
wild type, S. aureus 15981, and the 15981-ΔTCS15
(15981-ΔTCS15 hssRS), which harbour a deletion of
both the response regulator hssR and the histidine
kinase hssS [18].
The MIC for plectasin was determined for all the
strains using the microbroth dilution method (Table 1)
and a mutation in the hssR response regulator in S. aur-
eus lead to a 2 to 4 fold increased resistance compared
to the wild type, regardless of the genetic background.
This is in agreement with the initial finding, where we
used 4 fold MIC in the plate screen for transposon
mutants. A complementation of 8325-4 hssR::bursa
(8325-4 hssR::bursa/pRMC2-hssRS) decreased the resis-
tance 2 fold compared to the 8325-4 hssR::bursa (Table
1). The deletion of the rr23 in L. monocytogenes had no
effect on the resistance towards plectasin (Table 1).
In addition, we tested whether the two-component
system is involved in altered sensitivity to other antimi-
crobial peptides namely novispirin (a cathelicidin), novi-
cidin (a cathelicidin), protamine (a linear peptide) and
eurocin (a plectasin-like defensin). The S. aureus hssR/
hssRS mutants were also more resistant to eurocin, the
only other defensin, but were not altered in sensitivity
to other groups of peptides (Table 1).
The ability of the S. aureus hssR mutants to cope with
higher concentrations of the peptide compared to the
wild type was confirmed in a growth experiment. The
strains were grown with plectasin (in concentrations
known to inhibit growth) or without plectasin. The wild
type did not grow in the presence of plectasin, but the
response regulator mutants all grew (Figure 2). Comple-
menting 8325-4 hssR::bursa (8325-4 hssR::bursa/
pRMC2-hssRS) lead to plectasin inhibited growth com-
parable to the growth of wild type (Figure 2A). The
growth experiment also showed that the mutant and
wild type strains have similar growth kinetics when
grown in TSB (Figure 2). In vitro, S. aureus 8325-4 was
killed rapidly by plectasin (1× MIC), confirming the
results from Mygind et al [6]. The 8325-4 hssR::bursa
mutant was killed slower than the wild type (Figure 3).
Both HrtAB and HssRS are required for growth of
S. aureus in hemin [14]. When we examined the growth
of the hssR mutant compared to the wild type we also
found it to be almost completely inhibited by 4 μM
hemin, regardless of the presence or absence of plectasin
(Figure 4). The expression of hrtAB efflux system has
previously been shown to increase 45 fold by exposure
to hemin through transcriptional activation by HssR
[19]. However, we found no change of expression of
hrtB and hssR in the wild type when plectasin was
added using northern blot and quantitative real-time
PCR (P > 0.05).
Plectasin does not affect protein secretion
Recent work has shown that exposing hrtA mutants to
hemin, leads to increased protein secretion, however,
when exposing hssR mutants to hemin, a similar change
in secretion was not observed [14,20]. To investigate
whether plectasin induces a change in protein secretion,
we compared the L. monocytogenes and S. aureus wild
types to the hssR mutants. We found no difference in
the abundance of extracellular proteins, when the strains
were grown with or without plectasin (data not shown).
Stress and antibiotic resistance of hssR mutant cells
The relatively small number of TCSs in S. aureus and
L. monocytogenes imply that some of them are able to
sense several different stressors. In Streptococcus
Table 1 MIC values of host defence peptides against S. aureus and L. monocytogenes wild types and two-component
system mutants.
MIC (μg/ml)
Strain Description Plec Euro Prot NovC NovS
8325-4 S. aureus wild type 16 32 16 1 128
8325-4 hssR::bursa Transposon mutant 32 64 16 1 128
8325-4 hssR::bursa/pRMC2-hssRS Complementation of hssR transposon mutant 16 32 nd nd nd
8325-4 hssR Transduced 8325-4 hssR mutant 32 64 16 1 128
15981 S. aureus wild type 8 8 16 1 >128
15981 ΔTCS15 (hssRS) hssRS deletion mutant 32 32 16 1 >128
LO28 L. monocytogenes wild type 64 128 16 1 16
LO28 RR23 rr23 insertion mutant 64 128 16 1 16
Plec: plectasin, Euro: eurocin, Prot: protamine, NovC: novicidin, NovS: novispirin. nd: not determined.
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pyogenes the TCS CovRS, senses both iron starvation,
antimicrobial peptides and several other stressors [21].
We have found that HssR affects the resistance towards
defensins in addition to heme concentrations, we there-
fore determined if the HssRS TCS affects susceptibility
to other types of stress. However, when the S. aureus
and L. monocytogenes wild types and mutants were sub-
jected to a variety of stress-conditions; growth at 15°C,
30°C, 37°C or 44°C, or growth with the addition of 4%
NaCl, we found no difference in growth between the
wild types and their respective mutants. We also exam-
ined the sensitivity of wild type and mutants to several
antibiotics, i.e. ampicillin, gentamicin, sulfa/trimetho-
prim, rifampicin, tetracycline, amoxy/clavulan, cephalo-
tin, clindamycin, enrofloxacin, fusidic acid and oxacillin.
No change in MIC values was observed when the wild
type S. aureus and L. monocytogenes and the corre-
sponding response regulator mutants were compared
(data not shown). Thus, as opposed to the CovRS TCS,
HssR/RR23 from S. aureus and L. monocytogenes do not
seem to sense other types of stress. The results for
RR23 correspond with previous experiments, showing
no stress phenotype for an rr23 mutant [22].
Discussion
In the present study, we investigated how the antimicro-
bial peptide, plectasin, affects two human pathogens.
Our results indicate that plectasin and another defensin,
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Figure 2 Growth of S. aureus 8325-4 (A) and 15981 (B) wild types and hssR mutants in the presence of plectasin. Plectasin (35 μg/ml)
inhibited the growth of S. aureus 8325-4 and 15981 wild-types but hardly affected the growth of the 8325-4 hssR::bursa transposon mutant, the
transduced 8235-4 hssR mutant or the 15981 ΔTCS15 (hssRS) mutant. Complementation of 8325-4 hssR::bursa (8325-4 hssR::bursa/pRMC2-hssRS)
affected the growth slightly, but addition of plectasin inhibited the growth to a level comparable to wild type. The experiment shown is
representative of three independent experiments.
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eurocin, do not perturb the S. aureus and L. monocyto-
genes membrane, but differentially affect the bacterial
survival. These results are in agreement with recent
findings, which show that plectasin does not compro-
mise membrane integrity [6,12]. However, the non-
defensins, novicidin and protamine did lead to increased
leakage, implying that the antimicrobial activity of these
peptides involves disruptions of the bacterial membranes
(Figure 1).
To identify genes involved in resistance to plectasin,
we screened transposon mutant libraries of L. monocyto-
genes and S. aureus. We were unable to identify any
L. monocytogenes mutants more resistant to the peptide
compared to wild type. The L. monocytogenes wild-type
is more tolerant to plectasin (MIC >64 μg/ml) com-
pared to the S. aureus wild type (MIC = 8-16 μg/ml),
which might explain the difficulties in obtaining L.
monocytogenes mutants with decreased sensitivity [[6,7],
this work]. Four isolated S. aureus mutants, more resis-
tant to plectasin, had the transposon element inserted
in the response regulator hssR that is part of a TCS,
HssRS, involved in sensing heme concentrations [14]. A
primary mechanism by which bacterial cells respond to
changes in the environment is through the action of
TCSs. TCSs typically consist of a membrane-bound his-
tidine kinase that responds to environmental signals by
undergoing autophosphorylation followed by transfer of
the phosphoryl group to the regulator [23]. During con-
tact with a host, S. aureus acquire heme as iron source,
but surplus heme can be toxic. The HssRS system is
important for sensing the level of heme, and for activat-
ing the ABC transporter system HrtAB, which protects
the bacteria against heme-mediated damage [16,17].
Changes in iron availability are an environmental signal
indicative of mammalian host-pathogen interaction and
the HssRS TCS seems to be important for S. aureus to
sense and respond to heme as a component of verte-
brate blood [24,14].
Our results reveal that a mutation in hssR increases
the resistance of S. aureus to two defensin-like HDPs,
suggesting that the mutation of hssR leads to enhanced
bacterial resistance to immune clearance. Defensins are
an important part of the mammalian immune response
and mutant pathogens, more susceptible to HDPs, are
often attenuated in virulence, indicating that the intrin-
sic resistance to HDPs plays a key role in bacterial
infection [25]. Recently, a link between iron starvation
and HDP resistance in Yersinia pseudotuberculosis has
been shown, supporting the idea that bacteria can sense
when inside a host and coordinate their response
accordingly [26].
It has previously been reported that a mutation in
S. aureus hssR or hrtA leads to increased virulence [14].
This increase has been suggested to be due to pore
formation in the bacterial cell membrane that elicits an
increased secretion of immunomodulatory factors,
which decreases killing of the bacteria [20]. However,
plectasin does not form pores or leads to increased
secretion of bacterial compounds. These results indicate
that the deletion of hssR affects the bacteria in a way
that improve their ability to survive defensins of the
host defence system causing the observed hyperviru-
lence [14].
We did not observe an upregulation of hssR or hrtB
when S. aureus was exposed to plectasin. Previous
results have shown a 45 fold upregulation of hrtAB
when exposed to exogenous hemin [19]. The lack of
plectasin regulation of the systems implies that the TCS
does not sense the defensins and the ABC transporter
system HrtAB is not involved in exporting the peptides.
This suggests that the lack of hssR alleviates a regulation
of one or more target genes leading to the resistant phe-
notype. Modifications of the cell surface are known to
affect HDP resistance and plectasin targets bacterial cell
wall precursor Lipid II, implying a function of HssR on
the cell wall synthesis or composition. Change in surface
charge is known to affect HDP susceptibility and we
have previously shown that mprF and dltA mutations
affect S. aureus sensitivity to plectasin, novicidin, prota-
mine and novispirin [7]. However, the effect of the hssR
mutation is probably not due to changes in surface
charge, since only plectasin and eurocin susceptibilities
are altered.
A consensus DNA binding sequence for HssR has
been predicted and genomic analysis of S. aureus has
revealed that, besides the consensus sequence in the
hrtAB promoter region, 14 genes have consensus sites
containing 3-4 mismatches [16]. Whether one of these
genes is involved in the observed plectasin resistance
remains elusive. Further work is needed to clarify
whether the hssR mutation has an effect on one of these
genes in order to understand the bacterial changes that
lead to reduced plectasin sensitivity.
Homologues of the HrtAB and HssRS systems are
found in several Gram-positive bacterial pathogens
[[14], this work]. A possible HssR homologue, RR23,
exists in L. monocytogenes. However, a mutation in this
response regulator did not affect growth or survival
when exposed to the peptides and previous results have
shown that RR23 is not important for virulence [22].
Our results show that the susceptibility to defensins can
be decreased in S. aureus but not in L. monocytogenes.
This inability to obtain more resistant L. monocytogenes
mutants could be explained by the difference in MIC
values between the strains, showing that L. monocyto-
genes is 4-8 fold more tolerant to plectasin compared to
S. aureus. Whether this difference in sensitivity towards
plectasin between L. monocytogenes and S. aureus can
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be explained by the variations in virulence factors and
different routes of infection of the two pathogens
remains elusive.
Conclusions
We found that the S. aureus response regulator HssR,
but not the corresponding RR23 from L. monocytogenes,
is involved in the organisms’ sensitivity to defensins,
exemplified by plectasin. The mutation of hssR leads to
increased resistance towards plectasin and eurocin. The
HssRS two component system have previously been
shown to be important for heme homeostasis and an
hssR mutation leads to increased virulence [14]. Taken
together these results further indicate the importance of
this system in sensing environmental cues and respond-
ing accordingly. This result support the notion that the
system is able to sense internal host tissue and shift to
an immune evasive response and that the mutation in
hssR leads to enhanced bacterial resistance to host
immune factors. During the course of infection, the bac-
teria must not only cope with iron starvation but also
resist antimicrobial peptides, including defensins.
Whether the difference in responding to the HDPs
between L. monocytogenes and S. aureus is due to the
differences in infection processes still remains unclear.
However, our results indicate a functional difference
between RR23 and HssR and the genes regulated by
these regulators, which might explain the difference in
HDP susceptibility between the two strains.
Methods
Strains, plasmids and culture conditions
Bacterial strains and plasmids are described in Table 2.
For complementation, a PCR amplification of hssRS was
cut (KpnI-SacI) and cloned into the KpnI-SacI sites of
pRMC2, transformed into E. coli DH5a (Invitrogen) and
further transformed into 8325-4 hssR::bursa. Primers for
amplifying hssRS: Complement1-Forward-KpnI:
(5’ATCAGGGTACCGAAAAAGATAAGGGAGTTTA
3’), Complement3-Reverse-SacI:(5’CGCTGAGCTCTTT
CAGGAGGTAGAGATTAA3’). The 8325-4 hssR inser-
tion mutant was constructed by 11-mediated general-
ized transduction as previously described [27].
The bacteria were grown in Brain Heart Infusion
broth (BHI, CM0225 Oxoid) (L. monocytogenes) or
Tryptone Soy Broth (TSB, CM0129 Oxoid) (S. aureus).
When appropriate, antibiotics were added at the follow-
ing concentrations erythromycin 5 μg/ml (L. monocyto-
genes) and 10 μg/ml (S. aureus), chloramphenicol
10 μg/ml, tetracycline 12.5 μg/ml (Sigma) and
200 ng/ml anhydrotetracycline (Sigma).
Host defence peptides
Protamine was purchased from Sigma (P4020-5G). Plec-
tasin, eurocin, novicidin, and novispirin G10 were sup-
plied by Department of Antiinfective Discovery,
Novozymes A/S. The host defence peptides were dis-
solved in 0.01% acetic acid/0.1% bovine serum albumin
(Sigma, A7906).
Determination of the effect of plectasin on the bacterial
envelope - ATP measurements
L. monocytogenes and S. aureus were grown in TSB at
37°C. Bacteria were harvested (10 min at 3000 RPM) at
mid-exponential phase (absorbance at 546 nm of 2.5 ±
0.2 and 1.0 ± 0.2 for S. aureus and L. monocytogenes,
respectively), washed once in 50 mM potassium phos-
phate buffer pH 7.0 and once in 50 mM HEPES buffer
pH 7.0. The pellet was resuspended in 50 mM HEPES
pH 7.0 to a final absorbance at 546 nm of 10. Bacteria
were stored on ice and used within 5 hours. Bacteria
were energized in 50 mM HEPES (pH 7.0) with 0.2%
(wt/vol) glucose and treated with 500 μg/ml plectasin or
eurocin. ATP was determined using a bioluminescence
kit (Sigma, FLAA-1KT) and a BioOrbit 1253 lumin-
ometer. Total ATP content was determined by rapidly
Table 2 Strains and plasmids used in this study
Strains Relevant characteristic Reference
S. aureus 8325-4 wild type [27]
8325-4 hssR::bursa resistant mutant, bursa insertion This work
8325-4 hssR hssR mutation transduced from 8325-4 hssR::bursa This work
S. aureus 15981 wild type [34]
S. aureus 15981ΔTCS15 hssRS deletion [18]
8325-4 hssR::bursa/pRMC2-hssRS Complementation of the transposon mutant This work
L. monocytogenes 4446 wild type [35]
L. monocytogenes LO28 wild type [36]
LO28 RR23 rr23 mutant [22]
Plasmids
pRMC2 Tetracycline inducible expression vector [37]
pRMC2-hssRS hssRS cloned into pRMC2, complementation plasmid This work
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permeabilising 20 μl cell suspension with 80 μl dimethyl
sulfoxide. The cell suspension was diluted in 4.9 ml ster-
ile water, and ATP content was determined in 100 μl of
the preparation as described by the manufacturer. To
determine the extracellular ATP concentration, the 20
μl cell suspension was mixed with 80 μl sterile water
and analyzed as described above. Intracellular ATP con-
centrations were calculated by using the intracellular
volumes of 0.85 and 1.7 μm3 for S. aureus and L. mono-
cytogenes, respectively. The number of cells in suspen-
sion was determined by plate spreading.
Extracellular protein
Prewarmed TSB and BHI (25 ml) in a 250 ml Erlen-
meyer flask was inoculated with S. aureus strains and
L. monocytogenes strains, respectively. These flasks were
grown with and without plectasin at 37°C overnight
(≈ 17 h) with shaking. The next morning, the exact
absorbance at 600 nm of the cultures was measured,
and 15 ml of culture was centrifuged to precipitate the
cells (6 000 RPM; 7 min; 0°C). The supernatant was
transferred to a 50 ml Blue cap bottle (placed in an ice/
water bath), and the extracellular proteins were precipi-
tated by adding one volume of ice-cold 96% EtOH and
left in the refrigerator overnight for proteins to precipi-
tate. Precipitated proteins were collected by centrifuga-
tion (11,000 RPM; 30 min; 0°C). Protein pellets were
suspended in a volume of 50 mM Tris-HCl (pH 6.8)
adjusted to the original absorbance of the overnight cul-
ture so that 15 ml of overnight culture with absorbance
at 600 nm of 5.0 was suspended in 0.8 ml of 50 mM
Tris-HCl (pH 6.8). A sample of 15 μl of the protein
extracts was analysed on NuPAGE® 4-12% Bis-Tris gels
(Invitrogen) using the X Cell SureLock® Mini-Cell sys-
tem (Invitrogen) as recommended by the supplier. The
gels were Coomassie stained using GelCode® Blue Stain
Reagent (Pierce).
DNA-binding analysis
Gel retardation analysis were performed as described by
Nan et al by mixing 100 ng of plasmid DNA (pBlue-
script II SK+(Stratagene)) with increasing amounts of
peptide in 20 μl binding buffer (5% glycerol, 10 mM
Tris, 1 mM EDTA, 1 mM dithiothreitol, 20 mM KCL
and 50 μg ml-1 bovine serum albumin) [28]. Reaction
mixtures were incubated 1 h at room temperature and
subjected to 1% agarose gel electrophoresis and visua-
lised using ethidium bromide.
Transposon library in L. monocytogenes and S. aureus
Transposon mutagenesis of L. monocytogenes 4446 was
performed with the temperature-sensitive plasmid
pLTV1 as described, but with modifications [29].
L. monocytogenes 4446 harbouring pLTV1 was grown
overnight at 30°C in BHI containing 5 μg/ml erythro-
mycin. The bacterial culture was then diluted 1:200 in
BHI containing 5 μg/ml erythromycin and grown for 6
h at 42°C. Aliquots were plated onto BHI containing 5
μg/ml erythromycin plates and incubated at 42°C.
Colonies were harvested from the plates in BHI and
stored in 30% glycerol at -80°C. To determine the
transposition frequency, the transposon library was
plated onto BHI containing 5 μg/ml erythromycin.
One hundred colonies were picked and streaked onto
BHI plates containing 5 μg/ml erythromycin, 10 μg/ml
chloramphenicol, and 12.5 μg/ml tetracycline, respec-
tively, and incubated at 30°C for 48 h. The transposi-
tion frequency was calculated as the percentage of
colonies growing only on BHI + 5 μg/ml erythromycin
and BHI+10 μg/ml chloramphenicol (harbouring only
the transposon) but not on BHI+12.5 μg/ml tetracy-
cline (still harbouring the plasmid). Transposon muta-
genesis of S. aureus 8325-4 with bursa aurealis was
performed as described [30].
Screening of transposon library for plectasin
resistant mutants
The transposon mutant libraries were screened on agar
plates for increased resistance to plectasin as compared to
wild-type sensitivity. Wild-type sensitivity was determined
by plating approx. 1.0 × 107 CFU/ml on TSB agar contain-
ing plectasin (S. aureus) and approx. 1.0 × 105 CFU/ml on
Muller Hinton Broth agar plates (MHB, 212322 Becton
Dickinson) with plectasin (L. monocytogenes). Plates were
incubated at 37°C for 3 days and inspected for growth.
The transposon libraries were screened on TSB agar with
300 μg/ml, 500 or 750 μg/ml plectasin (S. aureus) or MHB
plates with 250 μg/ml or 500 μg/ml plectasin (L. monocy-
togenes) at 37°C for up to 7 days.
Identification of transposon mutant
Chromosomal DNA was purified from resistant mutants
using FAST DNA kit, Bio101, Qiagen, Germany). Identifi-
cation was performed as described by Bae et al [30]. AciI
was used to digest chromosomal DNA for 3 h at 37°C and
thereafter ligated with T4 ligase. The ligated DNA was
purified with the QIAquick PCR purification kit (Qiagen,
Germany). DNA fragments carrying transposon/chromo-
some junction sequences were amplified by PCR with the
following primers: Martn-F (5’ TTT ATG GTA CCA TTT
CAT TTT CCT GCT TTT TC 3’) and Martn-ermR
(5’AAA CTG ATT TTT AGT AAA CAG TTG ACG
ATA TTC 3’). The annealing temperature was 63°C, and
the DNA was amplified for 3 min with 40 cycles. PCR pro-
ducts were TOPO cloned according to the manufacturer
(Invitrogen, USA). Plasmids were sequenced using M13
forward (5’GTAAAACGACGGCCAGT 3’) and M13
reverse (5’AACAGCTATGACCATG 3’).
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Determination of Minimum Inhibitory Concentrations
(MIC) of antimicrobial peptides in liquid medium
Minimal inhibitory concentrations (MIC) of plectasin,
eurocin, protamine, novicidin, and novispirin G10 were
determined using a microbroth dilution method [31].
Colonies from a BHI plate incubated overnight at 37ºC
were suspended in MHB pH 7.4 to an absorbance at
546 nm of 0.11-0.12 at 546 nm (approx. 1.0 ×
108 CFU/ml) and diluted in MHB to a concentration of
5.0 × 105 CFU/ml. Ninety μl of bacterial suspension was
incubated with 10 μl of peptide solution in polypropy-
lene 96-well plates (Nunc, 442587) for 18-24 h at 37°C.
The peptide solutions were made fresh on the day of
assay. The range of concentrations assayed were 0.25-
256 μg/ml for plectasin and eurocin, 0.125-128 μg/ml
for protamine and novispirin G10, and 0.031-32 μg/ml
for novicidin. MIC was the lowest peptide concentration
at which visual growth was inhibited.
Influence of hemin and plectasin on growth of S. aureus
Overnight cultures of S. aureus were diluted to an
absorbance at 600 nm of 0.05 in TSB with and without
4 μM hemin and/or 35 μg/ml plectasin and grown at
37°C. Measurements of the absorbance were made every
30 minutes.
In vitro bacterial killing
Overnight cultures of S. aureus wild type 8435-4, 8325-4
hssR::bursa and 8325-4 hssR::bursa/pRMC2-hssRS were
diluted 1000 fold in TSB and grown 2 hours at 37°C.
Samples were taken to time T = 0 and plated for CFU
determination. Plectasin (1× MIC) was added, and sam-
ples were withdrawn after 1,3 and 5 hours growth at
37°C and plated for CFU determination.
Potential influence of plectasin on hssR and hrtB
expression
Wild type S. aureus and the hssR mutant were grown to
an absorbance at 600 nm of 0.45 ± 0.1, samples were
withdrawn for the isolation of RNA. Plectasin
(35 μg/ml) was added to the growing culture, and after
10 and 90 minutes samples were also withdrawn. Cells
were quickly cooled and lysed mechanically using the
FastPrep machine (Bio101; Q-biogene), and RNA was
isolated by the RNeasy kit (QIAGEN, Valencia, Calif.)
according to the manufacturer’s instructions. Northern
Blotting: RNA was transferred to a nylon membrane
(Boehringer Mannheim) by capillary blotting as pre-
viously described [32,33]. Hybridization was performed
using gene-specific probes that had been labelled with
[32P]dCTP using the Ready-to-Go DNA-labelling beads
from Amersham Biosciences. Primers for probes ampli-
fying hrtB and hssR: hrtB-1F:(5’CACTCAATAAAT-
GTCTTGTC3’), hrtB-2R: (5’AAGGTAATTCATCAAGA
ACC3’), hssR-1F: (5’AATGTCTTGTTGTCGATGAC3’),
hssR-2R:(5’ TTATAGCCTTGTCCTCTTAC3’). All steps
were repeated in two independent experiments giving
similar results. Quantitative RT-PCR: RNA was treated
with DNase and RevertAid™ H Minus first strand cDNA
synthesis Kit (Fermentas). The Mx30000P® and Maxima®
SYBR Green/ROX qPCR Master Mix (Fermentas) was
used essentially as described by the manufacturer. The
Real-Time reaction was run under the following condi-
tions: Segment 1: Initial denaturation 95C 10 minutes,
Segment 2: 95°C 30 s, 55°C 1 min, 72°C 30 s, for 40
cycles, Segment 3: 95°C 1 min, ramp down to 50°C and
ramp up from 50°C to 95°C. Primers amplifying hrtB
(Per1-F + Per2-R), hssR (RR1-F+ RRS-R) and ileS (ileS-
Forward + ileS-Reverse) which was used for normalisa-
tion: Per1-F:(5’TGAGGCACCTAAAATCGCTAC3’),
Per2-R:(5’GGGAGAATATTTCGTTATTTGAACAC3’),
RR1-F:(5’ACATTGATGCATACACACAACC3’), RR2-R:
(5’GTCAACTGTTCGCTCATCTCC3’), ileS-Forward:
(5’TTTAGGTGTTCGTGGTGA3’), ileS-Reverse:(5’CT
TTATCTGCCATTTCTCC3’). All steps were repeated
in three independent experiments giving similar results.
Statistical analysis on QRTPCR results using GraphPad
prism5, 1Way Anova with Dunnett’s Multiple compari-
son test (GraphPad Software, Inc) determined changes
in expression comparing time 0 to time 10 minutes or
90 minutes.
Stress and antibiotic resistance of S. aureus and L.
monocytogenes
Cultures of S. aureus and L. monocytogenes were grown
exponentially in TSB and BHI, respectively, at 37°C. At
an absorbance at 600 nm of 0.2 +/- 0.05 the cultures
were diluted 10-1, 10-2, 10-3 and 10-4fold, and 10 μl of
each dilution was spotted on TSB or BHI plates. The
plates were incubated at the indicated temperatures. In
addition plates containing 4% NaCl were spotted and
incubated in a similar way.
Antimicrobial susceptibility to ampicillin, gentamicin,
sulfa/trimethoprim, rifampicin, tetracycline, amoxy/cla-
vulan, cephalotin, clindamycin, enrofloxacin, fusidic acid
and oxacillin was performed with a commercially avail-
able MIC technique using dehydrated antimicrobials in
microtitre wells (Trek Diagnostic Systems Ltd., UK).
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